Theravance Biopharma says hypotension drug failed to meet primary goal

Theravance Biopharma

04/04/2022 21:19

April 4 (Reuters) - Theravance Biopharma Inc  TBPH.O  said
on Monday its experimental drug to treat a form of hypotension
failed to meet its primary goal for the overall population of
patients for which it was being tested.

 (Reporting by Leroy Leo in Bengaluru; Editing by Maju Samuel)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))